Federal cannabis policy is shifting. In December 2025, the U.S. President issued an executive order directing the Attorney General and federal agencies to move cannabis from Schedule I to Schedule III under the Controlled Substances Act. That action signals a pivotal moment for regulated cannabis across the nation and opens a path toward meaningful normalization for operators, investors, and regulators alike.
This is a strategic inflection point. Rescheduling won’t legalize cannabis overnight, and there will most likely be litigation around it, but this changes the legal and economic landscape faster and more profoundly than anything in the last decade.
The Strategic Importance of Schedule III
Right now, cannabis sits in Schedule I alongside substances the federal government categorizes as having no accepted medical use. Rescheduling to Schedule III formally recognizes medical value, reduces the severity of federal penalties, and removes one of the most punitive barriers to industry growth: IRS Code Section 280E.
280E currently prohibits state-legal cannabis businesses from deducting ordinary business expenses on their federal taxes. If cannabis moves into Schedule III, that restriction no longer applies and operators will finally be able to write off payroll, rent, marketing, equipment, and other legitimate costs just like any other legal business.
The ability to model business finances with standard deductions is a capital story. Banks, credit unions, private investors, and institutional lenders will see dramatically different risk profiles for cannabis businesses when they are no longer treated like federal outlaws.
What Rescheduling Means (and Doesn’t Mean)
Rescheduling is not federal legalization. Cannabis will remain federally controlled. There will be no nationwide adult-use market, and interstate commerce will remain prohibited absent separate congressional action.
Rescheduling does mean a new era of compliance and opportunity. Research hurdles fall. Industry perceptions shift. Access to capital improves. Strategic businesses will use this moment to prepare for a landscape where cannabis plays by many of the same financial and operational rules as alcohol, tobacco, and pharmaceuticals.
State Examples Illustrating Impact and Readiness
Minnesota: From New Market to Strategic Positioning
Minnesota’s cannabis program is young, yet it already shows how state dynamics matter in a national shift. Recreational legalization took effect in 2023, creating a surge of dispensaries and microbusiness licenses that could soon face an oversaturated retail environment.
For Minnesota operators, rescheduling will ease tax burdens just as competition tightens margins. Preparing now with strong financial systems and compliance playbooks ensures these brands can grow rather than struggle in a dense marketplace.
California: Legacy Market Meets Federal Reality
California has long been the nation’s largest legal cannabis market. Operators here have battled high taxes, regulatory complexity, and persistent federal risk. Rescheduling will help California brands reinvest in product innovation and workforce development by freeing up capital previously lost to punitive federal tax treatment.
Preparing now means integrating rescheduling scenarios into long-range plans, tax modeling, and investor communications.
Massachusetts: A Research and Medical Focus
Massachusetts is emerging as a leader in clinical and university research on cannabis. With Schedule III status acknowledging medical use, academic institutions and medical innovators can expand clinical research more easily, generating data that drives quality standards and expands patient access. Rescheduling makes that research economically and legally more feasible.
What Cannabis Businesses Should Do Today
Recalibrate Your Financial Model
Work with tax advisors and finance teams to model outcomes where 280E no longer applies. This affects valuation, capital structure, and growth forecasts.
Strengthen Compliance Frameworks
Rescheduling will bring new federal and state reporting expectations. Invest now in robust tracking systems, internal audit protocols, and compliance talent so your business is ready when rules change.
Communicate With Stakeholders
Investors and lenders are watching federal policy closely. Position your business narrative around preparedness, adaptability, and responsible regulation.
Engage with State Regulators
States that have legalized cannabis vary in how they align their tax codes and regulatory frameworks with federal policy. In some states, tax conformity is automatic; in others, it is not and that can affect cash flow and compliance strategies.
The Path Ahead
Rescheduling is a beginning. The official reclassification will go through a federal rulemaking process and legal challenges. But smart businesses do not wait for certainty to act. They build systems that anticipate change, they sharpen compliance engines, and they position themselves to lead as markets normalize.
Federal rescheduling presents risk and opportunity in equal measure. Businesses that prepare today will shape the competitive landscape of tomorrow.
Talk to a Cousin if you have questions.
